Search

everythinglearnresearchcommunity

for

Search:↓

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A new compound was effective for imaging prostate cancer in rats.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Large prostates link to more hair loss.

Finasteride treats hair loss but may affect prostate cancer detection.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Targeting FGF5 could help treat prostate cancer.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Plant-based compounds might be effective, low-side-effect treatments for prostate cancer by blocking a specific enzyme.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with PCOS have higher PSA levels, which are linked to increased male hormone levels and hirsutism.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

A castrated dog developed hair loss and prostate issues from long-term exposure to estrogen cream.

Finasteride treatment makes the prostate look more like a healthy one.

Long-term, low-dose finasteride may reduce the risk of benign prostatic hyperplasia and prostate cancer.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.